Phenylbutyrate exerts adverse effects on liver regeneration and amino acid concentrations in partially hepatectomized rats
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F16%3A10324924" target="_blank" >RIV/00216208:11150/16:10324924 - isvavai.cz</a>
Výsledek na webu
<a href="http://onlinelibrary.wiley.com.ezproxy.is.cuni.cz/doi/10.1111/iep.12190/epdf" target="_blank" >http://onlinelibrary.wiley.com.ezproxy.is.cuni.cz/doi/10.1111/iep.12190/epdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/iep.12190" target="_blank" >10.1111/iep.12190</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Phenylbutyrate exerts adverse effects on liver regeneration and amino acid concentrations in partially hepatectomized rats
Popis výsledku v původním jazyce
Phenylbutyrate is recommended in urea cycle disorders and liver injury to enhance nitrogen disposal by the urine. We report the effects of phenylbutyrate on liver regeneration and amino acid levels in plasma of partially hepatectomized (PH) rats. Phenylbutyrate or saline was administered at 12-h intervals to PH or laparotomized rats. Phenylbutyrate delayed the onset of liver regeneration compared to saline-treated controls, as indicated by lower hepatic DNA specific activities 18 and 24 hours post-PH, decreased hepatic fractional protein synthesis rates 24 hours post-PH, and lowered the increases in liver weights and hepatic protein and DNA contents 48 hours after PH. Hepatic DNA fragmentation (a hallmark of apoptosis) was higher in phenylbutyrate-treated animals than in controls. Phenylbutyrate decreased the glutamine and BCAA concentrations and the ratio of the BCAA to aromatic amino acids (phenylalanine and tyrosine) in the blood plasma in both hepatectomized and laparotomized animals. In conclusion, the delayed onset of liver regeneration and the decrease in BCAA to aromatic amino acid ratio in blood suggest that phenylbutyrate administration may be disastrous in subjects with acute hepatic injury and BCAA supplementation is needed when phenylbutyrate is used therapeutically.
Název v anglickém jazyce
Phenylbutyrate exerts adverse effects on liver regeneration and amino acid concentrations in partially hepatectomized rats
Popis výsledku anglicky
Phenylbutyrate is recommended in urea cycle disorders and liver injury to enhance nitrogen disposal by the urine. We report the effects of phenylbutyrate on liver regeneration and amino acid levels in plasma of partially hepatectomized (PH) rats. Phenylbutyrate or saline was administered at 12-h intervals to PH or laparotomized rats. Phenylbutyrate delayed the onset of liver regeneration compared to saline-treated controls, as indicated by lower hepatic DNA specific activities 18 and 24 hours post-PH, decreased hepatic fractional protein synthesis rates 24 hours post-PH, and lowered the increases in liver weights and hepatic protein and DNA contents 48 hours after PH. Hepatic DNA fragmentation (a hallmark of apoptosis) was higher in phenylbutyrate-treated animals than in controls. Phenylbutyrate decreased the glutamine and BCAA concentrations and the ratio of the BCAA to aromatic amino acids (phenylalanine and tyrosine) in the blood plasma in both hepatectomized and laparotomized animals. In conclusion, the delayed onset of liver regeneration and the decrease in BCAA to aromatic amino acid ratio in blood suggest that phenylbutyrate administration may be disastrous in subjects with acute hepatic injury and BCAA supplementation is needed when phenylbutyrate is used therapeutically.
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
ED - Fyziologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2016
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
International Journal of Experimental Pathology
ISSN
0959-9673
e-ISSN
—
Svazek periodika
97
Číslo periodika v rámci svazku
3
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
7
Strana od-do
278-284
Kód UT WoS článku
000380913100007
EID výsledku v databázi Scopus
2-s2.0-84979584096